SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-97-002865
Filing Date
1997-08-13
Accepted
1997-08-13 00:00:00
Documents
7
Period of Report
1997-06-30
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS FORM 10-Q 10-Q 65187
2 LEASE AGREEMENT EX-10.43 75056
3 CLINICAL TRIAL SUPPLY AGREEMENT EX-10.44 70151
4 NON-QUALIFIED STOCK OPTION AGREEMENT EX-10.45 36202
5 AMENDMENT TO DIRECTORS' STOCK OPTION PLAN EX-10.46 2248
6 STATEMENT RE: COMPUTATION OF NET LOSS PER SHARE EX-11.2 2774
7 FINANCIAL DATA SCHEDULE EX-27.2 2075
  Complete submission text file 0000950133-97-002865.txt   255703
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23736 | Film No.: 97659378
SIC: 2834 Pharmaceutical Preparations